184 related articles for article (PubMed ID: 18640802)
21. The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules/masses when compared with 18F-FDG-PET.
Hsieh HJ; Lin SH; Lin KH; Lee CY; Chang CP; Wang SJ
Ann Nucl Med; 2008 Jul; 22(6):533-8. PubMed ID: 18670862
[TBL] [Abstract][Full Text] [Related]
22. Integrated FDG-PET/CT vs. standard radiological examinations: comparison of capability for assessment of postoperative recurrence in non-small cell lung cancer patients.
Takenaka D; Ohno Y; Koyama H; Nogami M; Onishi Y; Matsumoto K; Matsumoto S; Yoshikawa T; Sugimura K
Eur J Radiol; 2010 Jun; 74(3):458-64. PubMed ID: 19398291
[TBL] [Abstract][Full Text] [Related]
23. Multimodal virtual bronchoscopy using PET/CT images.
Englmeier KH; Seemann MD
Comput Aided Surg; 2008 Mar; 13(2):106-13. PubMed ID: 18317959
[TBL] [Abstract][Full Text] [Related]
24. FDG-PET/CT imaging in assessing mucin-producing non-small cell lung cancer with pathologic correlation.
Shim SS; Han J
Ann Nucl Med; 2010 Jun; 24(5):357-62. PubMed ID: 20306161
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of serial [18F]fluorodeoxyglucose PET-CT uptake in stage III patients with non-small cell lung cancer treated by concurrent chemoradiotherapy.
Zhang HQ; Yu JM; Meng X; Yue JB; Feng R; Ma L
Eur J Radiol; 2011 Jan; 77(1):92-6. PubMed ID: 19695804
[TBL] [Abstract][Full Text] [Related]
26. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.
Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1432-41. PubMed ID: 16125870
[TBL] [Abstract][Full Text] [Related]
27. Dual-time point scanning of integrated FDG PET/CT for the evaluation of mediastinal and hilar lymph nodes in non-small cell lung cancer diagnosed as operable by contrast-enhanced CT.
Kasai T; Motoori K; Horikoshi T; Uchiyama K; Yasufuku K; Takiguchi Y; Takahashi F; Kuniyasu Y; Ito H
Eur J Radiol; 2010 Aug; 75(2):143-6. PubMed ID: 19446975
[TBL] [Abstract][Full Text] [Related]
28. To enhance or not to enhance? 18F-FDG and CT contrast agents in dual-modality 18F-FDG PET/CT.
Antoch G; Freudenberg LS; Beyer T; Bockisch A; Debatin JF
J Nucl Med; 2004 Jan; 45 Suppl 1():56S-65S. PubMed ID: 14736836
[TBL] [Abstract][Full Text] [Related]
29. Intra-tumour 18F-FDG uptake heterogeneity decreases the reliability on target volume definition with positron emission tomography/computed tomography imaging.
Dong X; Wu P; Sun X; Li W; Wan H; Yu J; Xing L
J Med Imaging Radiat Oncol; 2015 Jun; 59(3):338-45. PubMed ID: 25708154
[TBL] [Abstract][Full Text] [Related]
30. Virtual 18F-FDG PET/CT bronchoscopy for lymph node staging in non-small-cell lung cancer patients: present and future applications.
Buchbender C; Herbrik M; Treffert J; Forsting M; Bockisch A; Antoch G; Heusner TA
Expert Rev Med Devices; 2012 May; 9(3):241-7. PubMed ID: 22702254
[TBL] [Abstract][Full Text] [Related]
31. 18F-FDG PET/CT-related metabolic parameters and their value in early prediction of chemotherapy response in a VX2 tumor model.
Song SL; Deng C; Wen LF; Liu JJ; Wang H; Feng D; Wong CY; Huang G
Nucl Med Biol; 2010 Apr; 37(3):327-33. PubMed ID: 20346872
[TBL] [Abstract][Full Text] [Related]
32. Diagnosis of recurrence and assessment of post-recurrence survival in patients with extracranial non-small cell lung cancer evaluated by 18F-FDG PET/CT.
Jiménez-Bonilla JF; Quirce R; Martínez-Rodríguez I; Banzo I; Rubio-Vassallo AS; Del Castillo-Matos R; Ortega-Nava F; Martínez-Amador N; Ibáñez-Bravo S; Carril JM
Lung Cancer; 2013 Jul; 81(1):71-6. PubMed ID: 23597930
[TBL] [Abstract][Full Text] [Related]
33. Integrated PET/CT of salivary gland type carcinoma of the lung in 12 patients.
Jeong SY; Lee KS; Han J; Kim BT; Kim TS; Shim YM; Kim J
AJR Am J Roentgenol; 2007 Dec; 189(6):1407-13. PubMed ID: 18029878
[TBL] [Abstract][Full Text] [Related]
34. Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer.
Nestle U; Kremp S; Schaefer-Schuler A; Sebastian-Welsch C; Hellwig D; Rübe C; Kirsch CM
J Nucl Med; 2005 Aug; 46(8):1342-8. PubMed ID: 16085592
[TBL] [Abstract][Full Text] [Related]
35. Comparison of PET-CT images with the histopathological picture of a resectable primary tumor for delineating GTV in nonsmall cell lung cancer.
Lin S; Han B; Yu L; Shan D; Wang R; Ning X
Nucl Med Commun; 2011 Jun; 32(6):479-85. PubMed ID: 21394047
[TBL] [Abstract][Full Text] [Related]
36. Comparison of tumor volumes derived from glucose metabolic rate maps and SUV maps in dynamic 18F-FDG PET.
Visser EP; Philippens ME; Kienhorst L; Kaanders JH; Corstens FH; de Geus-Oei LF; Oyen WJ
J Nucl Med; 2008 Jun; 49(6):892-8. PubMed ID: 18483085
[TBL] [Abstract][Full Text] [Related]
37. Shortened acquisition protocols for the quantitative assessment of the 2-tissue-compartment model using dynamic PET/CT 18F-FDG studies.
Strauss LG; Pan L; Cheng C; Haberkorn U; Dimitrakopoulou-Strauss A
J Nucl Med; 2011 Mar; 52(3):379-85. PubMed ID: 21321263
[TBL] [Abstract][Full Text] [Related]
38. FDG PET/CT in cancer therapy monitoring: computer-assisted analysis of baseline together with up to two follow-ups.
Apostolova I; Renisch S; Opfer R; Derlin T; Buchert R; Carlsen IC; Brenner W
Nuklearmedizin; 2011; 50(2):83-92. PubMed ID: 21165536
[TBL] [Abstract][Full Text] [Related]
39. Tumor volume in subcutaneous mouse xenografts measured by microCT is more accurate and reproducible than determined by 18F-FDG-microPET or external caliper.
Jensen MM; Jørgensen JT; Binderup T; Kjaer A
BMC Med Imaging; 2008 Oct; 8():16. PubMed ID: 18925932
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of volume-based 18F-FDG PET/CT parameter in patients with surgically resected non-small cell lung cancer. Comparison with immunohistochemical biomarkers.
Lee JY; Choi JY; Heo JH; Han J; Jang SJ; Kim K; Kim J; Shim YM; Kim BT
Nuklearmedizin; 2016; 55(1):7-14. PubMed ID: 26875430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
